ATE304548T1 - Antibakterielle verbindungen - Google Patents

Antibakterielle verbindungen

Info

Publication number
ATE304548T1
ATE304548T1 AT03004404T AT03004404T ATE304548T1 AT E304548 T1 ATE304548 T1 AT E304548T1 AT 03004404 T AT03004404 T AT 03004404T AT 03004404 T AT03004404 T AT 03004404T AT E304548 T1 ATE304548 T1 AT E304548T1
Authority
AT
Austria
Prior art keywords
compounds
antibacterial compounds
xvi
xiv
xiii
Prior art date
Application number
AT03004404T
Other languages
English (en)
Inventor
Inukai Masatoshi
Kaneko Masakatsu
Takatsu Toshio
Hotoda Hitoshi
Arai Masatoshi
Miyakoshi Shunichi
Kizuka Masaaki
Ogawa Yasumasa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Application granted granted Critical
Publication of ATE304548T1 publication Critical patent/ATE304548T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/167Heterorings having sulfur atoms as ring heteroatoms, e.g. vitamin B1, thiamine nucleus and open chain analogs
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • C12P19/40Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
AT03004404T 1998-07-09 1999-07-09 Antibakterielle verbindungen ATE304548T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19428598 1998-07-09
JP26944598 1998-09-24

Publications (1)

Publication Number Publication Date
ATE304548T1 true ATE304548T1 (de) 2005-09-15

Family

ID=26508414

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99929772T ATE356825T1 (de) 1998-07-09 1999-07-09 Antibakterielle verbindungen
AT03004404T ATE304548T1 (de) 1998-07-09 1999-07-09 Antibakterielle verbindungen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99929772T ATE356825T1 (de) 1998-07-09 1999-07-09 Antibakterielle verbindungen

Country Status (23)

Country Link
US (2) US6472384B1 (de)
EP (3) EP1319666B1 (de)
KR (2) KR100622889B1 (de)
CN (1) CN1181087C (de)
AT (2) ATE356825T1 (de)
AU (1) AU751470B2 (de)
BR (1) BR9911965A (de)
CA (1) CA2337225C (de)
DE (2) DE69927306T2 (de)
DK (2) DK1095947T3 (de)
ES (2) ES2284260T3 (de)
HK (2) HK1053127B (de)
HU (1) HUP0103711A3 (de)
ID (1) ID27955A (de)
IL (3) IL140731A0 (de)
NO (1) NO322083B1 (de)
NZ (1) NZ509233A (de)
PL (1) PL200426B1 (de)
PT (1) PT1095947E (de)
RU (1) RU2209210C2 (de)
TR (1) TR200100059T2 (de)
WO (1) WO2000002892A1 (de)
ZA (1) ZA200100200B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI245047B (en) * 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives
EP1322504A1 (de) 2000-09-25 2003-07-02 Volkswagen AG Airbagvorrichtung und betriebsverfahren dafür
US7456222B2 (en) * 2002-05-17 2008-11-25 Sequella, Inc. Anti tubercular drug: compositions and methods
US20040033986A1 (en) * 2002-05-17 2004-02-19 Protopopova Marina Nikolaevna Anti tubercular drug: compositions and methods
CN101404986B (zh) * 2002-05-17 2011-09-28 赛奎拉公司 用于诊断和治疗感染性疾病的组合物和制药方法
WO2005034857A2 (en) * 2003-09-05 2005-04-21 Sequella, Inc. Methods and compositions comprising diamines as new anti-tubercular therapeutics
EP1771435A4 (de) * 2004-06-19 2008-02-13 Human Biomolecular Res Inst Modulatoren von neurotransmittern des zentralen nervensystems
US20090068325A1 (en) * 2007-09-10 2009-03-12 Gil Depicciotto Method of treatment of fresh produce
WO2009136965A1 (en) * 2008-05-06 2009-11-12 Sequella, Inc. Compositions and methods comprising capuramycin analogues

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60259190A (ja) * 1984-06-06 1985-12-21 Kanto Ishi Pharma Co Ltd 新抗生物質カプラマイシン及びその製造法
US5034381A (en) 1988-01-07 1991-07-23 Ciba-Geigy Corporation 2-(substituted amino) adenosines as antihypertensives
JPH05148293A (ja) * 1991-11-28 1993-06-15 Mect Corp 新規カプラマイシン誘導体およびその製造方法
GB9307043D0 (en) 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
TWI245047B (en) 1999-08-20 2005-12-11 Sankyo Co Novel A-500359 derivatives

Also Published As

Publication number Publication date
KR100729196B1 (ko) 2007-06-19
DE69927306D1 (de) 2005-10-20
NO20010105L (no) 2001-03-08
DE69935513T2 (de) 2007-11-29
DK1095947T3 (da) 2007-07-16
IL140731A0 (en) 2002-02-10
DK1319666T3 (da) 2005-12-05
KR20010083101A (ko) 2001-08-31
HK1053127A1 (en) 2003-10-10
DE69935513D1 (de) 2007-04-26
ES2248654T3 (es) 2006-03-16
IL140731A (en) 2008-06-05
WO2000002892A1 (en) 2000-01-20
EP1095947A1 (de) 2001-05-02
CA2337225A1 (en) 2000-01-20
HK1053127B (zh) 2005-12-30
KR100622889B1 (ko) 2006-09-12
BR9911965A (pt) 2001-05-29
NO322083B1 (no) 2006-08-14
CA2337225C (en) 2009-05-26
NO20010105D0 (no) 2001-01-08
HUP0103711A2 (hu) 2002-02-28
AU751470B2 (en) 2002-08-15
DE69927306T2 (de) 2006-07-06
EP1319666A1 (de) 2003-06-18
IL187551A0 (en) 2008-03-20
ATE356825T1 (de) 2007-04-15
IL187551A (en) 2009-12-24
PT1095947E (pt) 2007-06-20
HK1053063A1 (zh) 2003-10-10
EP1319406A1 (de) 2003-06-18
US6472384B1 (en) 2002-10-29
RU2209210C2 (ru) 2003-07-27
KR20060011919A (ko) 2006-02-03
US20030069204A1 (en) 2003-04-10
EP1319666B1 (de) 2005-09-14
AU4650599A (en) 2000-02-01
TR200100059T2 (tr) 2001-05-21
HUP0103711A3 (en) 2003-11-28
US6844173B2 (en) 2005-01-18
ID27955A (id) 2001-05-03
EP1095947B1 (de) 2007-03-14
EP1095947A4 (de) 2002-01-16
NZ509233A (en) 2003-05-30
CN1317008A (zh) 2001-10-10
ZA200100200B (en) 2002-06-26
PL345403A1 (en) 2001-12-17
CN1181087C (zh) 2004-12-22
PL200426B1 (pl) 2009-01-30
ES2284260T3 (es) 2007-11-01

Similar Documents

Publication Publication Date Title
IL187551A0 (en) Antimicrobial capuramycin derivatives and pharmaceutical compositions containing the same
GEP20094834B (en) Macrolides, pharmaceutical compositions containing them and their use for treatment of bacterial infections
GEP20063831B (en) Substituted bicyclic derivatives for treatment of abnormal cell growth
NZ506058A (en) Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
CY1106958T1 (el) Ν-αλκυλο-4-μεθυλεναμινο-3-υδροξυ-2-πυριδονες ως αντιμικροβιακα
DE69928952D1 (de) Chinolin-derivate und ihre verwendung als antibakterielle wirkstoffe
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
ZA9710796B (en) Oxyiminopregnanecarbolactones.
NO951198L (no) Lipopeptidderivater, fremgangsmåte for fremstilling derav og anvendelse av derivatene
NO331012B1 (no) N-sulfonyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler
MX9706231A (es) Derivados de 2-aminobenzazapina.
GEP20084437B (en) Novel lincomycin derivatives possessing antimicrobial activity
MX9708611A (es) Compuestos de dialquiltiacumicina.
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
MY104109A (en) Antibacterial 9-deoxo-9a-allyl and propargyl-9a-aza-9a-homoerythromycin a derivatives.
ATE250610T1 (de) Kaliumkanal-blockierende mittel
WO2002018353A3 (en) Oxazolidinone chemotherapeutic agents
FR2412564A1 (fr) Nouvelles 2' -n-acyl- et alkyl-6' -n-alkyl- et 6', 6' -di-n-alkyl-fortimicines a et b, utiles notamment comme antibiotiques
TR199801835A2 (xx) Antimikrobiyal kompozisyonlar.
PT852497E (pt) Utilizacao de derivados de prostano e a sua combinacao com antibioticos no tratamento de infeccoes bacterianas
DE60225834D1 (de) Antibiotika-ge-81112-faktoren a, b, b1, pharmazeutisch unbedenkliche salze und zusammensetzungen sowie verwendungen davon
NO982879L (no) Vannlöselige antibiotika
MD1105C2 (ro) N-(5-Nitro-2-furfuriliden)-4-aminobenzensulfamide, care manifestă activitate antimicrobiană
ECSP993176A (es) Nuevos compuestos y composiciones antibacterianas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1319666

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee